Article

Johns Hopkins' Sommer is winner of Helen Keller vision prize

Alfred Sommer, MD, dean of the Johns Hopkins Bloomberg School of Public Health and professor of ophthalmology, epidemiology, and international health, was named the 2005 recipient of the 12th annual Helen Keller Prize for Vision Research. Dr. Sommer received the award Monday at the annual meeting of the Association for Research in Vision and Ophthalmology.

May 3

- Fort Lauderdale, FL - Alfred Sommer, MD, dean of the Johns Hopkins Bloomberg School of Public Health and professor of ophthalmology, epidemiology, and international health, was named the 2005 recipient of the 12th annual Helen Keller Prize for Vision Research. Dr. Sommer received the award Monday at the annual meeting of the Association for Research in Vision and Ophthalmology.

Dr. Sommer was honored for his lifetime of dedication and accomplishment in vision research. He discovered the link between Vitamin A deficiency and childhood mortality, thus launching his career in public health and ophthalmology. He has made numerous seminal contributions in glaucoma, xerophthalmia, and cataract.

The Helen Keller Prize for Vision Research, presented by the Helen Keller Foundation for Research and Education, is awarded each year for research excellence as demonstrated by significant contributions throughout one's career or for a single contribution of exceptional importance. The prize includes an unrestricted honorarium of $30,000 and museum-quality portrait of Helen Keller.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.